Interpretation of regulatory framework stands in the way of NHS use of cheaper therapy for eye conditions
Research summary
Eye injection drugs recommended by NICE cost the NHS up to £447 million a year, but could be replaced by an unlicensed drug costing as much as ten times less. Use of the licensed drugs has increased three-fold over the last five years, with some parts of England treating five times as many patients as others.